Find-Speaker.com




3rd Annual Innate Killer Summit (description)

""

Category:Health & Wellness
Address:7450 Hazard Center Drive San Diego, California, United States of America 92108
Phone:+4402031418706
Event dates:3/27/2018 - 3/29/2018 (This event has already taken place)
Event web site:http://go.evvnt.com/173476-2
findCE GPA: This event is not yet rated. Click here to view a sample report card
Click here to rate 3rd Annual Innate Killer Summit

Speakers/Presenters:

Topics to be Covered:

  • Jeffrey Miller, Professor of Medicine, University of Minnesota, Wilfred Germeraad, Chief Scientific Officer, Chief Operating Officer and Co-Founder, Cimaas, Katy Rezvani, Chief, Section of Cellular Therapy at Department of Stem Cell Transplantation and Cellular Therapy MD Anderson, Cancer Center, Michael Caligiuri, Director of the Comprehensive Cancer Center CEO, James Cancer Hospital and Solove Research Institute, Ohio State University, Bob Valamehr, Vice President, Cancer Immunotherapy and Reprogramming Biology, Fate Therapeutics, Karl-Johan Malmberg, Professor of Immunology, University of Oslo, Joachim Koch Professor of Biochemistry, Goethe-University Frankfurt and Research Program Head Affimed, Mark Lowdell, Professor, Cell and Tissue Therapy, University College London, Sang Hoon Paik, General Manager / Head of Process Unit, Greencross, Nicholas Huntington, Molecular Immunology Laboratory Head, Walter and Eliza Hall Institute of Medical Research, Jan Spanholtz, Chief Scientific Officer and Research and Development Manager, Glycostem Therapeutics, Dan Kaufman, Professor of Medicine and Director of Cell Therapy, University of California, Sandip Patel, Assistant Professor, Medical Oncology/Hematology, UC San Diego Moores Cancer Center, Robin Pariha, r Assistant Professor, Center for Cell and Gene Therapy, Baylor College of Medicine, Eugene Zhukovsky, Chief Scientific Officer, Biomunex Pharmaceuticals, Katharine Hsu, Attending Physician and Member, Bone Marrow Transplantation, Memorial Sloan Kettering Cancer Center, Raymond Urbanski, Chief Medical Officer, GT Biopharma, Steve Doberstein, Chief Scientific Office and Senior Vice President of Research, Nektar Therapeutics
  • Science, Health and Medicine
Contact:georgina.fitzgerald@hansonwade.com
Organizer phone:+4402031418706
Offering type:Conference
Specialty:Data not provided
Event frequency:Never
First Meeting:
Total events:
Est. attendance:
Target audience:Any
Other target audiences:
Host Sponsor:Hanson Wade Ltd.
Est. # of exhibitors:
Currency:US Dollars
Language:English
CE Credits:
Organizer URL

Description:

As the cell immunotherapy field continues to explode beyond the well-hyped CAR-Ts, the Innate Killer Summit 2018 gathers the leading scientific and business experts from all the key stakeholders to identify future approaches to deliver commercially viable off-the-shelf therapies. By harnessing the unique power of the innate immune system, seize the enhanced drug development opportunity of NK cell immunotherapies. Capitalize on a more robust allogeneic development approach that overcomes common safety concerns experienced by other cell therapies. The 3rd Innate Killer Summit offers the platform for experts and leaders in the Innate Killer Community to come together, network and create collaborative partnerships. Learn from case studies on: Increasing Persistency and Specificity with CAR-NK – novel clinical data outlining methods to redirect NK cell specificity and in vivo persistence Combination Therapies to Support and Enhance Immunotherapeutic Response – explore the use of targeted antibodies and cytokines to work alongside NK cells to improve their role in persistence and anti-tumor effects Off-the-Shelf Allogeneic Therapies to Improve Accessibility of Treatment – utilize the capability of administering NK therapies as an “Off-the-Shelf” living drug Manufacturing Considerations to Improve Proliferation in NK Clinical Trials – create solutions to manufacturing hurdles specifically in regards to scaling up, expansion and increasing NK proliferative capabilities Regulatory Outline to Ensure Safety and Efficacy in NK Clinical Trials – identify the regulatory framework and procedures that surround NK research area

Schedule:

8:00 am - 4:00 pm

Registration Fee Details:

Gold: Conference and 2 Workshops: USD 2397
Silver: Conference and 1 Workshop: USD 2098
Bronze: Conference Only: USD 1599
Workshop Only: USD 499

Other items that tuition includes:

Travel and hotel arrangements:

 
 
Contact Person:Georgina FitzGerald
Contact Emailgeorgina.fitzgerald@hansonwade.com
Organizer State/Province: (Outside US)
Organizer CountryData not provided
Organizer Phone+4402031418706
Structural makeupOrganization
Host Sponsor; Other SponsorsHanson Wade Ltd.
Event Site/VenueThe DoubleTree by Hilton Hotel San Diego – Mission Valley
Event sold out?No
Multiple locations or dates?No
Statistics available for most recent event held in:NA
Average number in event attendance of:
Range:
Number in attendance of:
Range:
Target BoundariesInternational
Is Registration contact information the same as Organizer Contact above?Yes
Web Page http://go.evvnt.com/173476-0
Can one register for your CE on your web site?NA
Can registration be made by snail (regular) mail?Yes
Online housing reservations: 
 
Do you have additional written or AV materials for sale?No
If so, are they available for non-attendees as well as those attending?NA
Is full tuition necessary to ensure registration?No
Will there be shuttle service available?NA
Additional notes:Url: Brochure: https://go.evvnt.com/173476-1

Sign In/Sign Out
About Us
FAQ
Contact Us